Conduit Pharmaceuticals- Warrants (22/09/2028) Accounts Payable

As of the most recent data (June 2026), CDTTW shows a accounts payable of $360M. That compares with $300M in the prior-year period — up 18.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDTTW's accounts payable is now $360M (was $300M) — a 18.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Conduit Pharmaceuticals- Warrants (22/09/2028) is outperforming or lagging.

Tracking CDTTW's accounts payable over time shows whether Conduit Pharmaceuticals- Warrants (22/09/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $360M That compares with $300M in the prior-year period — up 18.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Conduit Pharmaceuticals- Warrants (22/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $360M) with ownership activity and broader fundamentals.